Lyophilized Injectables: Why Freeze-Drying Matters in Critical Care

Lyophilization — also called freeze-drying — is a low-temperature dehydration process used to stabilise pharmaceutical compounds that would otherwise degrade in liquid form. The drug is first frozen, then placed under vacuum, where the frozen water sublimates directly from solid to vapour without passing through a liquid phase. What remains is a porous, dry cake of active ingredient and excipients.

The result is a vial whose contents are chemically and physically stable for much longer than the corresponding liquid form — often years at controlled room temperature — and which can be reconstituted to its original concentration with sterile water or saline at the point of use.

Many high-impact hospital drugs — broad-spectrum antibiotics, antifungals, proton pump inhibitors, certain cytokine modulators — are chemically too unstable in solution to ship and store as ready-to-use liquids. Without lyophilization, supply chains for these agents would collapse within weeks of manufacture.

Freeze-dried presentation also gives the pharmacy team control over the final concentration and the choice of reconstitution diluent (typically Sterile Water for Injection, Sodium Chloride 0.9%, or Dextrose 5%, depending on the agent and the package insert).

Lyophilized vials are tolerant of a range of conditions but still require disciplined handling: protection from moisture (a broken seal can cake the powder), protection from direct light for photosensitive agents, and adherence to the temperature range specified on the package insert — usually 'do not exceed 30°C' for most parenterals in the ALTRAVAX portfolio, though some agents require strict 2–8°C cold chain.

After reconstitution, stability drops sharply. Most agents specify a use-within window (e.g. 'use immediately' or 'use within 1 hour at 25°C') because the now-dissolved drug begins to degrade on the same timescale it would have if shipped as a liquid in the first place.

ALTRAVAX distributes 20+ lyophilized SKUs across antifungals, antibiotics, and specialty agents — including Caspofungin, Micafungin, Anidulafungin, Colistimethate (in 1, 2, 3, and 4.5 MIU strengths), Polymyxin-B, Tigecycline, Voriconazole, and Pantoprazole.

Full SKU list and per-product compositions are on the catalogue page. Each batch is verified against Indian Pharmacopoeia specifications before it leaves our distribution centre.